Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Identification of potential biomarkers for patients with neurodegenerative parkinsonian syndromes using serum cytokine microarray analysis
Analyze with GEO2R
Identification of potential biomarkers for patients with neurodegenerative parkinsonian syndromes using serum cytokine microarray analysis; series 6
RayBio Human Cytokine Antibody Array G Series 2000; 6-8 array
Serum samples of internistic controls (INC) 2
Serum samples of internistic controls (INC) 1
Serum samples of healthy controls (HC) 4
Serum samples of healthy controls (HC) 3
Serum samples of healthy controls (HC) 2
Serum samples of healthy controls (HC) 1
Serum samples of patients with Parkinson’s disease (PD) 4
Serum samples of patients with Parkinson’s disease (PD) 3
Serum samples of patients with Parkinson’s disease (PD) 2
Serum samples of patients with Parkinson’s disease (PD) 1
Serum samples of patients with multisystem atrophy (MSA) 3
Serum samples of patients with multisystem atrophy (MSA) 2
Serum samples of patients with multisystem atrophy (MSA) 1
Serum samples of patients with progressive supranuclear palsy (PSP) or corticobasal syndrome (CBS) 3
Serum samples of patients with progressive supranuclear palsy (PSP) or corticobasal syndrome (CBS) 2
Serum samples of patients with progressive supranuclear palsy (PSP) or corticobasal syndrome (CBS) 1
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on